HEADER SURFACE ACTIVE PROTEIN 30-OCT-06 2NPV TITLE STRUCTURE AND DYNAMICS OF SURFACTIN STUDIED BY NMR IN MICELLAR MEDIA CAVEAT 2NPV BFC A 1 HAS WRONG CHIRALITY AT ATOM CB COMPND MOL_ID: 1; COMPND 2 MOLECULE: ELLVDLL; COMPND 3 CHAIN: A; COMPND 4 OTHER_DETAILS: THIS BIOSURFACTANT IS A CYCLIC LIPOPETIDE WITH SEVEN COMPND 5 AMINO-ACIDS (GLU-LEU-LEU-VAL-ASP-LEU-LEU) OF CONFIGURATION LLDLLDL COMPND 6 AND ONE BETA-AMINO FATTY ACID. SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BACILLUS SUBTILIS; SOURCE 3 ORGANISM_TAXID: 1423; SOURCE 4 OTHER_DETAILS: THIS PEPTIDE THAT CONTAINED AMINO ACIDS WITH SOURCE 5 CONFIGURATION D WAS PURIFIED FROM BACTERIA. FOR SUCH PEPTIDES, THE SOURCE 6 BACTERIA ARE USING MULTIENZYMATIC SYSTEMS THAT RACEMIZE AMINO ACID SOURCE 7 AND CATALYZE THE FORMATION OF PEPTIDIC BOND, AS FOR THE SYNTHESIS OF SOURCE 8 PEPTIDOGLYCANS FOR EXAMPLE. KEYWDS BIOSURFACTANT, CYCLIC LIPOPEPTIDE, SURFACTIN, SDS MICELLES, SURFACE KEYWDS 2 ACTIVE PROTEIN EXPDTA SOLUTION NMR NUMMDL 24 AUTHOR P.TSAN,L.VOLPON,J.M.LANCELIN REVDAT 5 25-DEC-24 2NPV 1 REMARK LINK REVDAT 4 27-DEC-23 2NPV 1 REMARK REVDAT 3 12-AUG-20 2NPV 1 CAVEAT REMARK LINK ATOM REVDAT 2 17-JUN-08 2NPV 1 JRNL VERSN REVDAT 1 28-NOV-06 2NPV 0 JRNL AUTH P.TSAN,L.VOLPON,F.BESSON,J.M.LANCELIN JRNL TITL STRUCTURE AND DYNAMICS OF SURFACTIN STUDIED BY NMR IN JRNL TITL 2 MICELLAR MEDIA JRNL REF J.AM.CHEM.SOC. V. 129 1968 2007 JRNL REFN ISSN 0002-7863 JRNL PMID 17256853 JRNL DOI 10.1021/JA066117Q REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.851, CHARMM 22 REMARK 3 AUTHORS : BRUNGER (X-PLOR), REMARK 3 BROOKS,BRUCCOLERI,OLAFSON,STATES,SWAMINATHAN,KARPLUS (CHARMM) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 THE STRUCTURES ARE BASED ON A TOTAL OF 49 RESTRAINTS, 47 ARE NOE- REMARK 3 DERIVED REMARK 3 DISTANCE CONSTRAINTS AND 2 ARE DIHEDRAL ANGLE RESTRAINTS REMARK 4 REMARK 4 2NPV COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 06-NOV-06. REMARK 100 THE DEPOSITION ID IS D_1000040157. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 5.1 REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 4MM SURFACTIN IN 90% H2O, 10% REMARK 210 D2O (PH 5.1); 50MM SDS-D25 REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : DQF-COSY; 2D TOCSY; 2D NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ REMARK 210 SPECTROMETER MODEL : DRX REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : GIFA 4.0, MOLMOL REMARK 210 METHOD USED : DISTANCE GEOMETRY, SIMULATED REMARK 210 ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 50 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 24 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LEAST REMARK 210 RESTRAINT VIOLATIONS, STRUCTURES REMARK 210 WITH THE LOWEST ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: THIS STRUCTURE WAS DETERMINED USING STANDARD 2D REMARK 210 HOMONUCLEAR TECHNIQUES REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 C LEU A 8 OB BFC A 1 1.28 REMARK 500 N GLU A 2 C BFC A 1 1.36 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 VAL A 5 -70.36 -89.99 REMARK 500 3 DLE A 4 -51.56 95.74 REMARK 500 6 DLE A 4 -53.35 116.44 REMARK 500 6 VAL A 5 -61.75 -90.08 REMARK 500 7 DLE A 4 -58.60 96.33 REMARK 500 7 DLE A 7 -53.41 95.95 REMARK 500 8 DLE A 4 -51.58 115.74 REMARK 500 8 VAL A 5 -61.96 -90.29 REMARK 500 9 DLE A 4 -57.25 96.59 REMARK 500 11 DLE A 4 -53.57 117.75 REMARK 500 11 VAL A 5 -67.23 -90.27 REMARK 500 13 DLE A 4 -57.29 101.40 REMARK 500 13 VAL A 5 -61.66 -90.04 REMARK 500 13 DLE A 7 -57.90 92.46 REMARK 500 14 DLE A 4 -51.74 108.09 REMARK 500 15 DLE A 4 -43.47 105.95 REMARK 500 15 ASP A 6 -61.20 -97.62 REMARK 500 16 DLE A 4 -56.74 101.92 REMARK 500 17 DLE A 4 -44.27 96.70 REMARK 500 18 VAL A 5 -64.34 -90.30 REMARK 500 19 DLE A 4 -50.35 114.02 REMARK 500 19 VAL A 5 -62.43 -90.22 REMARK 500 20 DLE A 4 -52.94 116.55 REMARK 500 20 VAL A 5 -66.08 -90.30 REMARK 500 21 DLE A 4 -51.19 92.90 REMARK 500 23 VAL A 5 -63.18 -90.43 REMARK 500 24 DLE A 4 -50.98 111.71 REMARK 500 24 VAL A 5 -62.30 -90.16 REMARK 500 24 DLE A 7 -56.55 100.49 REMARK 500 REMARK 500 REMARK: NULL REMARK 630 REMARK 630 MOLECULE TYPE: LIPOPEPTIDE ANTIBIOTIC REMARK 630 MOLECULE NAME: (R)-3-HYDROXYTETRADECANAL REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 1 BFC A 1 REMARK 630 2 BFC A 1 REMARK 630 3 BFC A 1 REMARK 630 4 BFC A 1 REMARK 630 5 BFC A 1 REMARK 630 6 BFC A 1 REMARK 630 7 BFC A 1 REMARK 630 8 BFC A 1 REMARK 630 9 BFC A 1 REMARK 630 10 BFC A 1 REMARK 630 11 BFC A 1 REMARK 630 12 BFC A 1 REMARK 630 13 BFC A 1 REMARK 630 14 BFC A 1 REMARK 630 15 BFC A 1 REMARK 630 16 BFC A 1 REMARK 630 17 BFC A 1 REMARK 630 18 BFC A 1 REMARK 630 19 BFC A 1 REMARK 630 20 BFC A 1 REMARK 630 21 BFC A 1 REMARK 630 22 BFC A 1 REMARK 630 23 BFC A 1 REMARK 630 24 BFC A 1 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: NULL REMARK 630 DETAILS: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BFC A 1 DBREF 2NPV A 2 8 PDB 2NPV 2NPV 2 8 SEQRES 1 A 7 GLU LEU DLE VAL ASP DLE LEU MODRES 2NPV DLE A 4 LEU D-LEUCINE MODRES 2NPV DLE A 7 LEU D-LEUCINE HET DLE A 4 19 HET DLE A 7 19 HET BFC A 1 42 HETNAM DLE D-LEUCINE HETNAM BFC (R)-3-HYDROXYTETRADECANAL FORMUL 1 DLE 2(C6 H13 N O2) FORMUL 2 BFC C14 H28 O2 LINK C LEU A 3 N DLE A 4 1555 1555 1.34 LINK C DLE A 4 N VAL A 5 1555 1555 1.35 LINK C ASP A 6 N DLE A 7 1555 1555 1.35 LINK C DLE A 7 N LEU A 8 1555 1555 1.35 SITE 1 AC1 3 GLU A 2 LEU A 3 LEU A 8 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1